Found 41 matching trials
Go-CHOP as the Frontline Therapy for PTCL PHASE2 This is a phase 2 Study to investigate the safety, tolerability, and anti-t...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma PHASE3 This is a multicenter, randomized, double-blind, placebo-controlled phase I...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Chidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell Lymphoma PHASE1 This is a Phase I/II, open-label, single-arm study investigating the combin...
Show More Location
Multiple Locations
Learn More & Join Trial
Golidocitinib Combined With Selinexor for CAEBVD PHASE2 This study is a multicenter, prospective, single-arm clinical investigation...
Show More Location
Beijing Friendship Hospital
Learn More & Join Trial
Go-CHOP in de Novo Intestinal T-cell Lymphoma Patients PHASE2 The goal of this observational study is to evaluate the safety and efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial
Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23) PHASE2 This study will treat patients with newly diagnosed PTCL, who have no prior...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Golidocitinib Plus CHOP in Newly Diagnosed PTCL PHASE1 This is single-arm phase I/II study designed to evaluate the safety and eff...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
A Single-Arm, Phase โ
b Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLC PHASE1 This study is a phase Ib, single-center, single-arm exploratory clinical st...
Show More Location
241, West Huaihai Road, Shanghai, Shanghai, Shanghai 200030
Learn More & Join Trial
A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study PHASE2 To learn if the study drug golidocitinib given alone or in combination with...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma PHASE1 This is a prospective, multicenter, open-label, phase Ib/II clinical study ...
Show More Location
Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University
Learn More & Join Trial